These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5669350)

  • 1. [The electrolyte content of donor blood in frequently repeated plasmapheresis].
    Gutnik RB; Zinevich AK
    Vrach Delo; 1968 Feb; 2():150-1. PubMed ID: 5669350
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of the cardiovascular system in donors undergoing multiple, frequently repeated plasmapheresis].
    Gutnik RB; Iaralova PV; Muravova LP; Kovalkina LA; Khazan LD
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):27-9. PubMed ID: 7220517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of plasmapheresis on immunoglobulin levels in blood donors].
    Yokoyama S; Matsuura N; Saji H; Hosoi T
    Rinsho Ketsueki; 1986 Jul; 27(7):1238-41. PubMed ID: 3784002
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions in healthy blood donors undergoing plasmapheresis.
    Schroeder ML; Buskard N; Herbert M; Kelton J; Rock G; Sternbach M
    Prog Clin Biol Res; 1990; 337():485-6. PubMed ID: 2353009
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
    Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
    Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extensive study of donor plasmapheresis using a membrane method by the special study group of the Japanese Red Cross Society.
    Ikeda H; Tomono T; Sakai E; Endo N; Yokoyama S; Ogawa M; Shiraki H; Kameko S; Sekiguchi S
    Prog Clin Biol Res; 1990; 337():503-6. PubMed ID: 2112757
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood coagulation in plasma donors].
    Kriazhev LN; Timofeev GA; Novosadov VM
    Probl Gematol Pereliv Krovi; 1982 Apr; 27(4):28-30. PubMed ID: 7100138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of plasmapheresis on female blood donors].
    Abe U; Sakamoto H; Kiyokawa H
    Rinsho Ketsueki; 1985 Nov; 26(11):1855-9. PubMed ID: 3835295
    [No Abstract]   [Full Text] [Related]  

  • 13. Current plasmapheresis practices in the United States.
    Crispen JF
    Dev Biol Stand; 1980; 48():297-301. PubMed ID: 7274561
    [No Abstract]   [Full Text] [Related]  

  • 14. Large volume donor plasmapheresis in inherited thrombophilia implicated in arterial thrombosis.
    Ovali E; Ratip S; Ozmenoglu M; Karti SS; Uçar F; Ukinç K; Yilmaz M; Koşucu P
    Transfus Apher Sci; 2003 Jun; 28(3):201-6. PubMed ID: 12725943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactions observed in blood donors and patients during cytapheresis on the blood cell separator].
    Gorodetskiĭ VM
    Ter Arkh; 1978; 50(7):129-31. PubMed ID: 715711
    [No Abstract]   [Full Text] [Related]  

  • 16. Which are the principal established or potential risks for donors undergoing cytapheresis procedures and how can they be prevented?
    Vox Sang; 1980 Sep; 39(3):169-79. PubMed ID: 7210606
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma collection and donor safety in rural China.
    Dodd RY
    J Infect Dis; 2005 Nov; 192(10):1681-2. PubMed ID: 16235163
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of long-term plasmapheresis on the donors blood picture].
    Smálik S; Beranová G; Filová J
    Bratisl Lek Listy; 1972 Nov; 58(5):545-57. PubMed ID: 4651574
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracorporeal blood volume of donors during automated intermittent-flow plasmapheresis and its relevance to the prevention of circulatory reactions.
    Karger R; Slonka J; Junck H; Kretschmer V
    Transfusion; 2003 Aug; 43(8):1096-106. PubMed ID: 12869116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.